CAMBRIDGE, Mass., Oct. 6 /PRNewswire-FirstCall/ -- Idenix Pharmaceuticals, Inc. announced today that Jean-Pierre Sommadossi, Ph.D., Idenix's chairman and chief executive officer, will present a corporate overview and review company milestones at the upcoming BIO Emerging Company Investor Forum 2004 on Thursday, October 14, 2004 at 12:10 p.m. PDT at The Palace Hotel in San Francisco.
The live and archived webcast of these presentations can be accessed under "Events" in the Idenix Investor Center at http://www.idenix.com/. The archived replay will be available on the Idenix website for two weeks following the presentation.
About Idenix:
Idenix Pharmaceuticals, Inc. is a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral and other infectious diseases. Idenix's current focus is on the treatment of infections caused by hepatitis B virus, hepatitis C virus and human immunodeficiency virus (HIV). Idenix's headquarters are located in Cambridge, Massachusetts and it has drug discovery operations in Montpellier, France and Cagliari, Italy.
Contact: Idenix Pharmaceuticals, Inc. Media: Teri Dahlman (617) 995-9905 Investors: Amy Sullivan (617) 995-9838
Idenix Pharmaceuticals, Inc.CONTACT: Media: Teri Dahlman, +1-617-995-9905; or Investors: AmySullivan, +1-617-995-9838 both of Idenix Pharmaceuticals, Inc.
Web site: http://www.idenix.com/
